Infringement in Switzerland through globally accessible website

Case No. O2019_007 | Decision of 19 November 2021 | ‘Gene sequencing’

Illumina Cambridge had sued Latvia MGI Tech for infringement of two patents, i.e. EP 1 530 578 B1 (cf. EPO Register and Swissreg) and EP 1 828 412 B2 (cf. EPO Register and Swissreg); ¶ 27.

In brief, the judgment holds that both patents are valid (EP 578: ¶ 33 et seqq; EP 412: ¶ 53 et seqq.) and infringed (EP 578: ¶ 84 et seqq; EP 412: ¶ 91 et seqq.).

Decision of 19 Nov 2021, Illumina Cambridge Ltd. v. Latvia MGI Tech SIA: infringement in Switzerland through globally accessible website; both CH EP 1 530 578 and 1 828 412 found valid and infringed by MGI’s reagents kits, https://t.co/rWpXYMW5Or pic.twitter.com/8vFSZEC8sd

— Swiss Patent Court (@PatentCourt) December 7, 2021

Further, the globally accessible website en.mgitech.cn (and a brochure «presumably» (‘mutmasslich’) downloaded therefrom) is considered as sufficient evidence of infringement in Switzerland (offer of «[…] installation validation services, including all the reagents required for delivering such services»); ¶ 25-26.

The judgment can still be appealed to the Supreme Court.

/MW

—

BIBLIOGRAPHY

Case No. O2019_007 | Decision of 19 November 2021 | ‘Gene sequencing’

Illumina Cambridge Limited
./.
Latvia MGI Tech SIA

Panel of Judges:

• • Dr. Mark SCHWEIZER
  • Dr. Tobias BREMI
  • Dr. Michael KAUFMANN

Judge-rapporteur:

• • Dr. Tobias BREMI

Court Clerk:

• • Dr. Lukas ABEGG

Representative(s) of Plaintiff:

• • Dr. Andri HESS (Homburger)
  • Julian SCHWALLER (Homburger)
  • Andrea HEINIGER (Homburger)
  • Dr. Claudia BIBUS (Blum), assisting in patent matters

Representative(s) of Defendant:

• • Dr. Thierry CALAME (Lenz & Staehelin)
  • Lara DORIGO (Lenz & Staehelin)
  • Dr. Martin WILMING (Hepp Wenger Ryffel), assisting in patent matters

—

JUDGMENT IN FULL

—

PATENTS IN SUIT

EP 1 530 578 B1:

–

EP 1 828 412 B2:

—

BE ON THE KNOW